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ABSTRACT
Introduction Limited evidence exists on the cost-
effectiveness of interventions to prevent obesity and
promote healthy body image in adolescents. The SHINE
(Supporting Healthy Image, Nutrition and Exercise) study is
a cluster randomised control trial (cRCT) aiming to deliver
universal education about healthy nutrition and physical
activity to adolescents, as well as targeted advice to
young people with body image concerns who are at risk
of developing disordered eating behaviours. This paper
describes the methods for the economic evaluation of the
SHINE cRCT, to determine whether the intervention is cost-
effective as an obesity prevention measure.
Methods and analysis A public payer perspective will be
adopted, with intervention costs collected prospectively.
Within-trial cost-effectiveness analysis (CEA) and cost-
utility analysis (CUA) will quantify the incremental costs
and health gains of the intervention as compared with
usual practice (ie, teacher-delivered curriculum). CEA will
present results as cost per body mass index unit saved.
CUA will present results as cost per quality-adjusted
life year gained. A modelled CUA will extend the target
population, time horizon and decision context to provide
valuable information to policymakers on the potential
for incremental cost offsets attributable to disease
prevention arising from intervention. Intervention costs
and effects will be extrapolated to the population of
Australian adolescents in Grade 7 of secondary school
(approximate age 13 years) and modelled over the
cohort’s lifetime. Modelled CUA results will be presented
as health-adjusted life years saved and healthcare
cost-savings of diseases averted. Incremental cost-
effectiveness ratios will be calculated as the difference in
costs between the intervention and comparator divided by
the difference in benefit. Semi-structured interviews with
key intervention stakeholders will explore the potential
impact of scalability on cost-effectiveness. These data
will be thematically analysed to inform sensitivity analysis
of the base case economic evaluation, such that cost-
effectiveness evidence is reflective of the potential for
scalability.
Ethics and dissemination Ethics approval was obtained
from the Deakin University Human Research Ethics
Committee (#2017–269) and the Victorian Department of
Education and Training (#2018_003630). Study findings
will be disseminated through peer-reviewed academic

Strengths and limitations of this study
►► This protocol contributes to the limited body of evi-

dence on the cost-effectiveness of interventions that
prevent obesity and promote healthy body image in
adolescents.
►► Data collection for the economic evaluation is
prospectively planned alongside the randomised
controlled trial that will assess intervention
effectiveness.
►► The cost-effectiveness study design will generate
important information for decision-makers, providing evidence of the immediate ‘value-for-money’ of
the intervention.
►► A modelled economic evaluation will estimate the
long-term potential for cost-effectiveness of the intervention as an obesity prevention measure.
►► Qualitative exploration of the potential impacts of
the programme delivered at scale on costs, effects
and cost-effectiveness will provide important information on scalability of the intervention.
papers and participating schools will receive annual
reports over the 3 years of data collection.
Trial registration number ACTRN 12618000330246;
Pre-results.

INTRODUCTION
Overweight and obesity in adolescence is
a serious public health issue globally, with
both the mean body mass index (BMI) and
the prevalence of obesity in adolescents
increasing worldwide over the last four
decades.1 In Australia, approximately 30%
of boys and 24% of girls aged 15 to 17 years
were classified as overweight or obese in
2017/2018.2 Diet, physical activity and sedentary behaviour are recognised as modifiable
determinants of obesity at the individual
level, yet evidence suggests that many adolescents do not regularly engage in healthy
behaviours to reduce their risk of overweight
and obesity. For instance, in 2011/2012, less
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than 10% of Australian adolescents aged 12 to 17 years
met recommended daily physical activity guidelines3 and
recent evidence suggests that Australian children aged
14 to 18 years consume relatively high amounts of discretionary food, including cakes, biscuits, fried potatoes and
sugar-sweetened beverages.4
Overweight and obesity are associated with higher
healthcare costs and greater health burden within childhood and adolescence, including negative psychosocial consequences, lower educational attainment and
increased risk of sleep apnoea, hypertension, type 2
diabetes and asthma.1 5–7 Evidence also suggests that overweight and obesity in childhood and adolescence tracks
to adulthood,8 leading to adverse health consequences
throughout the life course related to chronic diseases
where excess body weight is a risk factor.9 Adolescence
has been identified as a period of vulnerability, when
many disordered eating behaviours and attitudes that
lead to weight gain emerge.10 The adolescent years introduce greater autonomy over food choice, a decrease in
breakfast consumption, increased frequency of snacking
and eating outside the home environment, more disposable income, stronger influence from peers and changes
in physical activity behaviours.11 Adolescence may therefore present a window for intervention to reduce body
weight and image concerns, and to improve nutrition and
physical activity behaviours.
The evidence for the effectiveness of obesity prevention
interventions in adolescents (ie, children aged 13 to 18
years) is currently limited and relatively inconclusive.12 13
An important finding from a recent Cochrane review was
that interventions to prevent childhood obesity do not
appear to result in adverse effects.13 Evidence suggests
that internet-
delivered interventions can reduce weight
and shape concerns in adolescents,14 15 however limited
evidence exists on the cost-effectiveness of such interventions. There is also extremely limited evidence to date on
the cost-effectiveness of interventions to reduce body weight
and encourage healthy nutrition and physical activity in
adolescents.16 Information on the cost-
effectiveness of
interventions is an important element in the decision-
making process, allowing for more informed resource allocation decisions in environments where there are infinite
wants and needs for health spending yet finite resources
in terms of funding allocated to health. Cost-effectiveness
evidence is often informed by data from controlled
research environments such as randomised controlled
trials (RCTs), however, there is also a need to better understand the potential impact of the scale-up of interventions
on the costs, effects and cost-effectiveness of obesity prevention interventions when delivered in the ‘real world’.16 17
Qualitative methods for economic evaluation have recently
been highlighted as promising for better understanding
of the contextual factors of implementation (eg, organisational, environmental, economic factors) that may be
relevant to decision-makers.18 These methods have not yet
been comprehensively applied to economic evaluations of
interventions conducted in controlled research settings to
2

provide valuable information on the impacts of scale-up in
less controlled environments.
The SHINE (Supporting Healthy Image, Nutrition and
Exercise) study is a cluster RCT (cRCT), with randomisation at the school level. SHINE aims to deliver universal
education about healthy nutrition, physical activity and
well-being behaviours to adolescents, as well as targeted
advice to young people who may be experiencing or are
at risk of developing mental health, weight or body image
disorders. The intervention replaces the usual Health
and Physical Education (HPE) curriculum for 8 weeks
and is a self-directed, online learning programme that is
modelled on cognitive behavioural therapy (CBT) to effect
change.19 The intervention aims to improve body image,
mental health, nutrition and physical activity and to help
prevent the development or progression of overweight and
obesity. The aim of this paper is to describe the protocol
for the economic evaluation of the SHINE cRCT. The
evaluation will address the research question of whether
the SHINE intervention is cost-effective for reducing BMI
and increasing physical activity, as compared with usual
practice. The economic considerations of future scale-up
of the intervention will also be explored using qualitative
methods. Combined, this will provide important information on the cost-effectiveness of the intervention and
its potential for wider implementation across Australian
secondary schools.

METHODS AND ANALYSIS
Design overview
Within-
trial cost-
effectiveness analysis (CEA) and cost-
utility analysis (CUA) will be undertaken alongside the
SHINE study, quantifying the incremental costs and health
gains of the intervention as compared with usual practice
(ie, teacher-
delivered curriculum). Decision-
analytical
modelling will then extend the target population, time
horizon and decision context from the within-trial results,
to provide valuable information to policymakers on the
potential for incremental cost offsets attributable to disease
prevention as a result of the intervention. CEA and CUA
will be conducted at 36 months using an intention-to-treat
approach. Cost-
effectiveness of the SHINE intervention
will be determined using the commonly accepted Australian threshold of $A 50 000 per quality-adjusted life year
(QALY) gained.20 A qualitative study will also explore the
economic implications of scale-up on the costs, effects and
cost-effectiveness of the SHINE intervention should it be
implemented at scale. Reporting of the economic evaluation will follow the Consolidated Health Economic Evaluation Reporting Standards (CHEERS)21 and a CHEERS
checklist will be completed.
Study population
Trial participants will be Grade 7 students (approximately
13 years of age) attending 30 secondary schools across
metropolitan Melbourne and country Victoria, Australia.
Brown V, et al. BMJ Open 2020;10:e038050. doi:10.1136/bmjopen-2020-038050
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Figure 1 Timeline for the SHINE-SFA randomised controlled trial. HRQoL,health-related quality of life; SHINE, Supporting
Healthy Image, Nutrition and Exercise.

Intervention and comparator
The SHINE intervention will consist of an online
programme, delivered in weekly sessions of approximately 50 min over eight consecutive weeks during
scheduled HPE lessons as per the national curriculum.19
The programme consists of four themes on healthy
habits—nutrition, physical activity, emotions and body
(self) image—and each theme has multiple modules
that can be completed in approximately 5 min. In addition to the online programme, data will be collected
via questionnaires at baseline (T1), post-
intervention
(T2), 12 months (T3), 24 months (T4) and 36 months
(T5)(figure 1). The questionnaires include screening
measures for depressive symptoms and eating disorder
symptoms. The measures used are the short form of
the Center for Epidemiologic Studies – Depression
Scale (CESD10)22 and the Adolescent version of the
Eating Disorder Examination-
Questionnaire (EDE-
A).23 Results from these screening measures at baseline
will identify participants who are experiencing or are
at-risk of having depression, eating disorders or weight
issues so that they can receive targeted content in the
SHINE intervention. The pathways for completion are
directed and content is progressively presented,
self-
with the targeted content surreptitiously delivered so as
to avoid potential stigma or embarrassment. Intervention content is based on an effective programme originally developed for college students in the USA (the
‘Staying Fit’ programme24 25), and modified as both a
universal and targeted intervention for adolescents in
Brown V, et al. BMJ Open 2020;10:e038050. doi:10.1136/bmjopen-2020-038050

the Australian context. The intervention online content
is based on CBT and provides goal setting and suggested
self-help strategies to alter unhelpful or unhealthy ways
of thinking about common adolescent problems to
support behaviour change. Class teachers will receive
a training manual on how to access and support the
SHINE programme (including a telephone hotline for
teachers available during intervention implementation
to troubleshoot any potential technical issues). A website
comprising of key content from the intervention will
be available for parents to access during the course of
the intervention, as these have previously been demonstrated to improve parental attitudes towards weight and
shape14 26 and are associated with better outcomes.27
Booster SHINE sessions will be delivered to students
during one class period in both Grades 8 and 9, 2 and
3 years after commencement of the programme. The
study timeline is given in figure 1.
The comparator for the intervention is defined as
the waitlist control schools who will receive the usual
national HPE curriculum.19 Schools will be randomised
to intervention or waitlist-control arms using concealed
web-
based randomisation. Participation will be facilitated by ethics approval for passive consent, enabling all
students in Grade 7 at participating schools to receive
either the SHINE intervention or standard teacher-
delivered curriculum. The only students who will not
be captured are those with written opt-out/non-consent
from parents. Student assent will also be collected at
each assessment.
3

BMJ Open: first published as 10.1136/bmjopen-2020-038050 on 3 August 2020. Downloaded from http://bmjopen.bmj.com/ on August 19, 2020 at Washington University School of Medicine
Library &. Protected by copyright.

Open access

Sample size and missing data
We will recruit a minimum of 30 schools from metropolitan and regional Victoria. Assuming a high enrolment
rate associated with the opt-out consent approach28 we
expect to enrol an average of 150 seventh-
grade children per school, that is, a total of 4500 participants
(approximately 2250 in each group). Considering 20%
attrition, we aim to collect complete data on 3600 participants (1800 per group). This sample size provides 80%
power of detecting the following effect sizes at 36 months
(α=0.05 and two-sided tests) after allowing for clustering
of students in classes with the specified design effect (DE),
assuming the average number of participating students
per class will be 20.
Overweight and obesity prevalence
Assuming a 30% prevalence of overweight and obesity in
the control group at 36 months29 a sample of 3600 students
allows to detect a 5.8% point reduction in the prevalence
in the intervention group at 36 months (assuming Intraclass Correlation Coefficient (ICC)=0.05, DE=1.95) or a
4.9% point reduction (ICC=0.02, DE=1.38).30
BMI z-score
Assuming a conservative 30% prevalence of overweight
or obesity at baseline, we would have a sample of 540
such students in each arm. Assuming a SD of 0.38 for
BMI z-scores at 36 months in this group (informed by our
previous study), we would be able to detect a difference
of 0.05 points on the BMI z-score (assuming ICC=0.05,
DE=1.95) or 0.04 points (ICC=0.02, DE=1.38).
Outcome measures
Study outcome measures relevant to the economic evaluation are presented in table 1. Online questionnaires
will be used to collect all outcome data except height and
weight, which will be measured by trained research assistants at baseline, and at 8 weeks and 12, 24 and 36 months
from baseline.
The primary outcome measure for the within-trial CEA
will be the change in BMI at 36 months in the intervention group, as compared with the waitlist-control group.
The secondary outcome measure for within-trial CEA will
Table 1 Summary of outcome measures for economic
evaluation
Study outcome measure

Method for data collection

BMI, BMI z-score

Objectively measured height
and weight by trained research
assistants. BMI z-score estimated
using the WHO reference standard.

Quality of life

Online questionnaire using the
AQoL-6D45

Physical activity

Online questionnaire using the
APARQ46

APARQ, adolescent physical activity recall questionnaire; AQoL-
6D, assessment of quality of life 6D; BMI, body mass index.

4

include the time spent in physical activity in the intervention group, as compared with the waitlist-control group
at 12, 24 and 36 months. CUA will also be undertaken
using the difference in quality of life in the intervention
group, as referenced to the waitlist-control group at 12,
24 and 36 months. Quality of life will be measured using
the adolescent version of the Assessment of Quality of
Life 6D (AQoL-6D), a preference-based multi-attribute
utility instrument comprised of 20 items from six dimensions (independent living, relationships, mental health,
coping, pain and senses) with an adolescent-
specific
scoring algorithm.31 The items from the six dimensions
comprising the adolescent version of the AQoL-6D will
be used as the outcome measure for evaluation and utility
values will be adjusted for the adolescent population
using the adolescent specific preference weights.31
Resource use and intervention costs
Given the intervention is delivered in the school setting,
the economic evaluation will be conducted from the
public payer perspective. The public payer perspective
was chosen as both education and healthcare are publicly,
universally provided in Australia. The evaluation will be
undertaken assuming ‘steady state’ conditions (ie, the
intervention is assumed to be running at full effectiveness
and costs associated with the programme’s development
will not be included into the analyses). Incremental costs
from resource use associated with implementation of the
intervention will be identified using pathway analysis.
The research team will collect resource use data alongside the trial (up to 36 months post intervention) using a
standardised tool created in Microsoft Excel and a survey
of teacher time. Study invoices, receipts and published
values will be used for costing, with all costs measured
in 2021 Australian dollars. Costs will be reported as total
cost of the intervention, as well as mean cost per participant. Where appropriate, costs and consequences will be
discounted at the commonly accepted 3% discount rate.32
Table 2 provides a summary of the resource use and intervention costs to be collected alongside the SHINE cRCT.
Within-trial cost-effectiveness and cost-utility analyses
The within-trial CEA and CUA reference year will be 2021
and will include total costs and effects that accumulate
during the intervention period (up to 36 months from
baseline). Results will be presented as the cost per BMI
unit saved, cost per extra minute of physical activity
gained and the cost per QALY gained. Incremental cost-
effectiveness ratios (ICERs) will be calculated as the
difference in costs between the intervention and the
comparator divided by the difference in benefit.
Modelled cost-utility analysis
The modelled CUA will assume that the intervention is
integrated in national curriculum and will include costs
accumulated during the intervention implementation
phase and effects that accumulate over a longer time
horizon, assumed to be rest-of-life or 100 years of age.
Brown V, et al. BMJ Open 2020;10:e038050. doi:10.1136/bmjopen-2020-038050
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Table 2 Resource use and intervention costs collected alongside the SHINE cRCT
Cost category

Costs

Collection strategy and source of data

Time costs

Costs associated with training teachers on intervention
delivery. Costs associated with lesson planning. Salary
on-costs will be included.
Costs associated with travel for training or intervention-
related purposes.
Costs include teacher training materials, printing, and so
on. Consumables/materials costs.

Teacher time use survey
Published salary values from Government
websites47 48
Project administrative records
Published values from Government websites49
Project administrative records

Travel costs
Equipment costs

Costs are estimated assuming steady-state intervention (ie, excluding intervention development costs).
cRCT, cluster randomised control trial; SHINE, Supporting Healthy Image, Nutrition and Exercise.

Costs and effects will be extrapolated to reflect intervention delivery to the Australian population of Grade 7
students in all Government and non-Government schools.
A proportional multi-state, multiple cohort life table
Markov model developed as part of an obesity priority
setting study in Australia (the ACE-Obesity Policy model)
will be updated and used to estimate the obesity and
physical activity-related health outcomes and healthcare
cost-savings of the SHINE intervention.33 The reference
year will be 2018 for the modelled CUA, due to the availability of epidemiological data to inform the model. The
model uses the ‘relative risk shift’ method for the calculation of population impact fractions34 to estimate the
consequences of a change in BMI or a change in physical
activity on the incidence of related diseases. The obesity-
related diseases included in the model are ischaemic
heart disease, hypertensive heart disease, ischaemic
stroke, diabetes, colorectal cancer, kidney cancer, breast
cancer, endometrial cancer and osteoarthritis. Physical
activity-related diseases include ischaemic heart disease,
stroke, type 2 diabetes, breast cancer and colon cancer,
with an adjustment factor to avoid double-counting for
diseases where both obesity and physical inactivity are
risk factors.35 Cohort-based modelling will allow for the
disease-related benefits not present in adolescence to be
estimated assuming lingering BMI effects. Differences in
the health-related quality of life between healthy weight
and obese adolescents will be incorporated using utility
values derived from the study population using the
AQoL-6D Adolescent version.
The change in risk arising from a change in BMI and/
or physical activity will be compared against the counterfactual scenario, where the distributions of BMI and/or
physical activity in the 2018 Australian population (ie, the
reference population) remain unchanged. The model
will use data from the Australian Health Survey 2017–
20182 and disease epidemiology from the Global Burden
of Disease study36 (table 3). Healthcare costs will be estimated using data from the Australian Institute of Health
and Welfare, adjusted to 2018 values using the health
price index.37 Modelling will be undertaken in Microsoft
Excel and results will be presented as cost per life year
saved, cost per health-adjusted life years gained (HALYs
gained), healthcare cost-
savings from diseases averted
Brown V, et al. BMJ Open 2020;10:e038050. doi:10.1136/bmjopen-2020-038050

and mean ICER assuming maintenance of intervention
effect over the cohort’s lifetime. Results will be presented
on a cost-effectiveness plane, where interventions that are
both health-
promoting and cost-
saving are considered
‘dominant’.
Uncertainty and sensitivity analyses
The Microsoft Excel add-in Ersatz38 will be used to estimate the 95% uncertainty intervals around epidemiological probabilities and cost estimates using Monte Carlo
simulation (2000 runs). Sensitivity analyses will be undertaken for the modelled CUA by varying key assumptions
around the sustainability of the intervention effect. Sensitivity analyses will also vary the discount rate to 0% and
5% as per recommended guidelines.39
Qualitative analysis
Semi-structured interviews will be conducted with key intervention stakeholders to explore the potential for scalability
of the intervention, and the implications for costs, effects
and cost-effectiveness of the intervention if delivered at
scale. Key intervention stakeholders (n=20; defined as
potential programme providers (eg, education department
and curriculum authority representatives), programme
deliverers (eg, teachers and principals) and lead intervention researchers (eg, Chief and Associate Investigators,
Table 3 Input parameters for health impact modelling
Parameters

Data source and
assumptions

Total population estimates
(population numbers, mortality
rates, BMI distribution, PA levels)
Disease epidemiology, disability
weights

Australian Bureau of
Statistics2 50

Relative risks of PA-related
diseases by risk categories

Zapata-Diomedi et al
201652

Relative risks, total years of life
lived with disability
Disease healthcare costs

Institute for Health
Metrics and Evaluation51
Australian Institute of
Health and Welfare37

Institute for Health
Metrics and Evaluation51

BMI, body mass index; PA, physical activity.
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Project Manager)) will be purposively sampled and invited
to participate in face-to-face or telephone interviews. The
interviews will be guided by the Knowledge-
To-
Action
framework40 and the Consolidated Framework for Implementation Research41 and will be recorded and transcribed
verbatim. Data will be analysed thematically using NVivo
12 software to assist with data coding, and reported as per
guidelines.42 Data from the interviews will be summarised
narratively,43 and will also inform further sensitivity analysis of the modelled CUA by adjusting the cost and effect
estimates used to determine cost-
effectiveness at scale
according to qualitative findings.
Approvals and registration
The SHINE RCT has been registered with the Australian
New Zealand Clinical Trials Registry.
Ethics and dissemination
Ethics approval for the SHINE study has been received from
the Deakin University Human Research Ethics Committee
(#2017–269) and the Victorian Department of Education
and Training (#2018_003630). Data pertaining to the
economic evaluation of the intervention will be held on
secure servers at Deakin University, Australia, as per ethics
requirements. Publications planned using this data include
a peer-reviewed journal article on the cost-effectiveness of
the intervention at 36 months and a peer-reviewed journal
article exploring the potential impact on costs, effects and
cost-effectiveness of scale-up. Findings will be disseminated
both within academia, to the participating schools and to
policymakers. Study findings will be placed on the project
website (https://www.deakin.edu.au/cphr/our-research/
epidemiology-unit/research-projects/shine) to enable
viewing by study participants and their parents.

STRENGTHS
Results from the within trial CEA and CUA will be supplemented with results from a modelled CUA, examining the
broader potential for cost-effectiveness of the intervention
by extrapolating costs and effects to a wider population
and modelling over a longer time horizon. In addition,
mixed methods research will explore the potential impact
on costs, effects and cost-effectiveness should the SHINE
intervention be scaled up in future. The results from the
proposed economic evaluation will add to the relatively
limited evidence base on the ‘value for money’ of obesity
prevention interventions in adolescents, and will provide
useful information to decision makers both within the
health and education sectors on the economic case for
more widespread implementation of the intervention.

AQoL-6D missing data we will impute values within each
dimension as per developer guidelines. Sensitivity analyses will be used to assess the impact of the handling of
missing data on study findings. The modelled cost-utility
analysis will also be subject to several limitations, including
the assumptions used for extrapolating the outcomes and
costs from a short-term trial to longer-term healthcare
cost-savings and health benefits and the published limitations of the ACE-Obesity Policy model.33 Sensitivity analyses will be used to assess the impact of assumptions on
overall study findings.
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